Lonza
Presence
Lonza is one of the...
Lonza is a company listed under the stock ticker LONN (CH).
Lonza has a direct presence in 2 countries.
They are in:
- Biotechnology50%
- Pharmaceuticals50%
Executives
View the org chart displaying its 36 main executives
Most searched biographies at Lonza
- Albert Baehny, Interim Chief Executive Officer
- Barbara Richmond, Director
- Angelica Kohlmann, Director
Popular executive movements at Lonza
- Wolfgang Wienand will join the company as Chief Executive Officer in Jun. 2024 (posted on April 3 2024).
- Albert Baehny who is Chairman of the Board and Interim Chief Executive Officer, will become Interim Chief Executive Officer in Apr. 2024 (posted on January 26 2024).
- Jean-Marc Huët will join the company as Chairman of the Board in Apr. 2024 (posted on January 26 2024).
Click here to view some more movements at Lonza
Create your alert
to follow the executive moves at Lonza.
Biotechnology
Lonza has 2,273 competitors including Eurofins (Luxembourg), Adaptive Phage Therapeutics (United States (USA)) and Serina Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
- Nuvation Bio has announced the acquisition of AnHeart (posted on April 12 2024).
- D3 Bio has just announced a $62 Million fundraising (posted on April 12 2024).
Popular contacts in Biotechnology
News
Press releases by Lonza
- Lonza Launches GS Effex® Cell Line for the Development of Therapeutic Antibodies...
- Lonza Appoints Wolfgang Wienand as New Chief Executive Officer
- Lonza Publishes Invitation to the 2024 Annual General Meeting and 2023 Annual...
- Lonza Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) from Roche
- Journalist Inquiries | Lonza
- Jean-Marc Huët to succeed Albert M. Baehny as Chairman of Lonza
- Lonza erzielt im 2023 ein solides Ergebnis mit 10.9% (kWk) Umsatzwachstum und 29.8% Kern-EBITDA-Marge
- Lonza Delivers Solid 2023 Performance with 10.9% CER Sales Growth and 29.8% CORE EBITDA Margin
- Research & Development | Blog | Lonza
- Lonza Prices CHF 400 Million Dual-Tranche Straight Bonds
- View more press releases Close
Social media about Lonza
- Lonza on Wikipedia, Google News & Yahoo Finance
- Lonza on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Albert Baehny 
